Joint Formulary & PAD

Estradiol - Osteoporosis prophylaxis

You are here : Home > Formulary Search > Estradiol - Osteoporosis prophylaxis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Patches
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

NOTE - discontinuation of the Progynova TS weekly patch by Dec 2025. FemSeven weekly patch remains available or twice-weekly Evoral / Estraderm patches.

 

Status 2

Green (see narrative)
Formulations :
  • Gel
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Estradiol gel is a treatment option in patients where a topical formulation is more suitable than tablets.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Estradiol
Indication :
Osteoporosis prophylaxis
Group Name :
Keywords :
Brand Names Include :
Estraderm, Estradot, Evorel, FemSeven, Elleste Solo, Oestrogel, Sandrena
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

03 Sep 25 - Medicines Optimisation Operational Group (MOOG)

Users are signposted to use the NICE CKS guidance for the management of osteoporosis, available at https://cks.nice.org.uk/topics/osteoporosis-prevention-of-fragility-fractures/management/management/

The National Osteoporosis Guideline Group UK (NOGG) clinical guidelines are available here-  https://www.nogg.org.uk/sites/nogg/download/NOGG-Guideline-2021-g.pdf

Other Indications

Below are listed other indications that Estradiol is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Osteoporosis prophylaxis.

  • No records returned.